Jim Boonyaratanakornkit
Overview
Explore the profile of Jim Boonyaratanakornkit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Caban M, Rodarte J, Bibby M, Gray M, Taylor J, Pancera M, et al.
Nat Commun
. 2023 Feb;
14(1):798.
PMID: 36781872
Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza virus types one (HPIV1) and three (HPIV3) can cause severe disease and death in immunocompromised patients, the elderly, and those...
12.
Hill J, Kiem E, Bhatti A, Liu W, Keane-Candib J, Fitzpatrick K, et al.
Am J Transplant
. 2023 Feb;
23(3):416-422.
PMID: 36748802
Antibodies against foreign human leukocyte antigen (HLA) molecules are barriers to successful organ transplantation. B cell-depleting treatments are used to reduce anti-HLA antibodies but have limited efficacy. We hypothesized that...
13.
Doll M, Waghmare A, Heit A, Levenson Shakoor B, Kimball L, Ozbek N, et al.
medRxiv
. 2022 Nov;
PMID: 36425923
Importance: The U.S. arrival of the Omicron variant led to a rapid increase in SARS-CoV-2 infections. While numerous studies report characteristics of Omicron infections among vaccinated individuals and/or persons with...
14.
Gonzalez M, Bhatti A, Fitzpatrick K, Boonyaratanakornkit J, Huang M, Campbell V, et al.
Blood Adv
. 2022 Sep;
7(9):1849-1853.
PMID: 36094846
No abstract available.
15.
Boonyaratanakornkit J, Boeckh M, Waghmare A
Curr Opin Infect Dis
. 2022 Jul;
35(4):280-287.
PMID: 35849517
Purpose Of Review: Monoclonal antibody (mAb) administration represents an important strategy for preventing and treating respiratory viral infections in vulnerable populations, including immunocompromised individuals. The purpose of this review is...
16.
Elyanow R, Snyder T, Dalai S, Gittelman R, Boonyaratanakornkit J, Wald A, et al.
JCI Insight
. 2022 Apr;
7(10).
PMID: 35439166
BACKGROUNDMeasuring the immune response to SARS-CoV-2 enables assessment of past infection and protective immunity. SARS-CoV-2 infection induces humoral and T cell responses, but these responses vary with disease severity and...
17.
Hurlburt N, Homad L, Sinha I, Jennewein M, MacCamy A, Wan Y, et al.
Commun Biol
. 2022 Apr;
5(1):342.
PMID: 35411021
Three betacoronaviruses have crossed the species barrier and established human-to-human transmission causing significant morbidity and mortality in the past 20 years. The most current and widespread of these is SARS-CoV-2....
18.
Stewart J, Krows M, Schaafsma T, Heller K, Brown E, Boonyaratanakornkit J, et al.
JAMA Netw Open
. 2022 Feb;
5(2):e2148325.
PMID: 35157053
Importance: Racial and ethnic diversity among study participants is associated with improved generalizability of clinical trial results and may address inequities in evidence that informs public health strategies. Novel strategies...
19.
Vick S, Frutoso M, Mair F, Konecny A, Greene E, Wolf C, et al.
Sci Adv
. 2021 Nov;
7(46):eabj0274.
PMID: 34757794
Despite recent studies of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), little is known about how the immune response against SARS-CoV-2 differs from other respiratory infections. We compare...
20.
Walti C, Loes A, Shuey K, Krantz E, Boonyaratanakornkit J, Keane-Candib J, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34702753
Recipients of chimeric antigen receptor-modified T (CAR-T) cell therapies for B cell malignancies have profound and prolonged immunodeficiencies and are at risk for serious infections, including respiratory virus infections. Vaccination...